Halozyme Therapeutics, Inc. (BIT:1HALO)
61.96
0.00 (0.00%)
At close: Sep 5, 2025
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of €7.75 billion as of September 22, 2025. Its market cap has increased by 9.10% in one year.
Market Cap
7.75B
Enterprise Value
8.59B
Revenue
1.00B
Ranking
n/a
PE Ratio
16.33
Stock Price
€61.96
Market Cap Chart
Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 141.66M to 7.75B, an increase of 5,370.11%. That is a compound annual growth rate of 20.60%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 7.75B | 31.89% |
Dec 31, 2024 | 5.88B | 33.01% |
Dec 29, 2023 | 4.42B | -38.64% |
Dec 30, 2022 | 7.20B | 44.69% |
Dec 31, 2021 | 4.98B | 5.58% |
Dec 31, 2020 | 4.71B | 104.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UniCredit | 100.59B |
Intesa Sanpaolo | 95.97B |
Enel SpA | 78.68B |
Ferrari | 72.82B |
Assicurazioni Generali | 49.55B |
Eni S.p.A. | 45.18B |
Leonardo S.p.a. | 28.76B |
Poste Italiane | 25.78B |